Luminex continues to rack up FDA clearances for assays to use in its Aries systems. The Austin, Texas–based company said Wednesday that FDA has cleared an Aries assay for group B streptococcus. It’s the third assay FDA has cleared for use with Luminex’s Aries systems. The GBS assay has also received a CE-IVD marking. Luminex […]
Lab Instruments & Supplies
Fresenius Kabi wins FDA nod for Aurora Xi plasmapheresis system
Fresenius Kabi (NYSE:FMS) said today that it won FDA 510(k) clearance for its Aurora Xi plasmapheresis system. Plasma, a component of blood that contains proteins, is used in therapies to treat burn victims, bleeding disorders, and other chronic and genetic problems. Patients who require plasma infusions or injections have to get them regularly and often […]
Philips spectral CT used on T-Rex spine
Royal Philips (NYSE:PHG) said today that researchers at the Naturalis museum in Leiden, Netherlands used its IQon CT scanner to closely examine the tail vertebrae of a 66 million year-old T-Rex named Trix. Philips’ IQon scanner is the 1st detector-based spectral CT, using a dual-layer detector and advanced spectral reconstruction to compose a detailed image. Researchers […]
Metamark to sell Hologic’s Progensa prostate cancer test
Metamark Genetics said today it inked a collaborative deal to act as the exclusive worldwide sales agent for Hologic‘s (NSDQ:HOLX) Progensa PCA3 assay, designed to test for prostate cancer. The Progensa PCA3 is the 1st urine-based molecular test of its kind, according to Metamark. The test is designed to quantify cancer-specific overexpression of prostate cancer antigen […]
PositiveID acquires mobile lab developer E-N-G Mobile Systems
PositiveID (OTC:PSID) said today it acquired specialty vehicle and mobile lab developer E-N-G Mobile Systems for approximately $1 million. ENG’s fastest growing division was its mobile labs segment, which included chemical, biological, nuclear, radiological and explosives testing, PositiveID said. TheDelray Beach, Fla.-based company said it plans to add its bio-detection technology to the labs to offer […]
Theranos CEO Holmes hits pause
(Reuters) — Theranos CEO Elizabeth Holmes fought back yesterday against accusations that the technology at the heart of the blood-testing startup has grave flaws, telling the Wall Street Journal that the the Silicon Valley lab company is in a “pause period” while it seeks approval from the FDA. Holmes defended her company at a technology conference hosted in Laguna Beach by the […]
Med Fusion closes in on $66M funding goal
Med Fusion is closing the gap towards hitting its $65.7 million goal, having brought in $61.2 million so far.
Med Fusion has sold equity to 30 unnamed investors at a minimum investment of $9,000, according to a regulatory filing.
PE shop KKR spends $1.7B on 80% stake in Panasonic Health
Steris buys surgical instrument repair duo for $110M
Healthcare giant Steris (NYSE:STE) acquired surgical instrument repair businesses Spectrum Surgical Instruments Corp. and Total Repair Express for total of about $110 million.
The acquisitions are part of Steris’s efforts to its healthcare segment and provide niche services to customers, according to a company statement.
Bruker Announces Agreement to Acquire CETR
BILLERICA, Mass.–(BUSINESS WIRE)–Bruker Corporation today announced the signing of a purchase agreement
to acquire Center for Tribology, Inc. (CETR) for an undisclosed amount.
CETR, a privately held corporation located in Silicon Valley in
Campbell, CA, is projected to have calendar year 2011 revenue greater
than $10 million and EBITDA greater than $2 million. The transaction is
expected to close at the end of the third quarter of 2011, subject to
customary closing conditions. After the closing, Bruker intends to
continue to operate CETR in Silicon Valley and to integrate its business
management, operations, research and development, sales and support with
Thermo Fisher finally closes $2 billion Dionex deal
After six months of delays, the marriage between Thermo Fisher Scientific Inc. (NYSE:TMO) and Sunnyvale, Calif.-based Dionex Corp. (NSDQ:DNEX) was finally consummated.
The deal, first announced Dec. 13, 2010, was beset by several delays in clearing anti-trust hurdles in the European Union and the U.S.